Both in Pharmaceuticals
Rallybio vs Biomea Fusion
Over the past year RLYB returned +286.4% and BMEA returned −38.8%; their daily moves had a correlation of 0.14.
RLYB +286.4% BMEA −38.8%Growth of $1, one year, split-adjusted
| Metric | RLYB | BMEA |
|---|---|---|
| Price | $17.22 | $1.26 |
| Market cap | $91.5M | $91.3M |
| Today | +1.00% | −2.33% |
| 1 month | +2.4% | −27.2% |
| 6 months | +114.2% | −4.5% |
| Year to date | +213.7% | +1.6% |
| 1 year | +291.4% | −40.0% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 2.0× | — |
| Price / sales | 141.6× | — |
| Net cash | $92.8M | $34.8M |
| Dividend yield | — | — |
| Volatility (60d) | 20.8% | 73.0% |
| Short % of float | 2.4% | 20.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).